Results 31 to 40 of about 140,141 (234)

Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias

Brazilian Journal of Infectious Diseases
This manuscript reviewed the literature on infection by Mycoplasma pneumoniae with emphasis on etiological aspects of childhood community-acquired pneumonias.
Letícia Alves Vervloet, Christophe Marguet, Paulo Augusto Moreira Camargos   +2 more
doaj   +1 more source

Mycoplasma pneumoniaepneumonia in children

Korean Journal of Pediatrics, 2012
Mycoplasma pneumoniae (MP), the smallest self-replicating biological system, is a common cause of upper and lower respiratory tract infections, leading to a wide range of pulmonary and extra-pulmonary manifestations. MP pneumonia has been reported in 10 to 40% of cases of community-acquired pneumonia and shows an even higher proportion during epidemics.
Youn, You-Sook, Lee, Kyung-Yil
openaire   +2 more sources

Mycoplasma pneumoniae: Atypical Pathogen in Community Acquired Pneumonia

, 2020
Mycoplasma pneumoniae is a one of most common reasons of respiratory tract infections in both adolescents and children with severity ranged from moderate to high. Many facts in the previous years regarding infections were induced via this organism having
Abdul-Rahman Mamdouh Mohammad, Eman Farouk Ahmed, Rehab Mahmoud Abd El-Baky   +2 more
core   +1 more source

Association of mycoplasma pneumoniae and (rs9271366) HLA-DRB1gene polymorphism with the immune susceptibility to rheumatoid arthritis

Medical Journal of Babylon, 2023
Background: Rheumatoid arthritis (RA) is a chronic, inflammatory disease that affects the immune system. The primary cause of RA is unknown, but there is evidence that genetic and environmental factors also contribute to the development of the disease ...
Wael Rasheed Obaead Alfatlawi, Mohammed A K Al-Saadi, Adil Hasan Ali Akbar   +2 more
doaj   +1 more source

High Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in Children with Acute Respiratory Infections from Lima, Peru.

PLoS ONE, 2017
BackgroundMycoplasma pneumoniae and Chlamydia pneumoniae are atypical pathogens responsible for pneumonia and a leading cause of morbidity and mortality in low income countries.
Juana Del Valle-Mendoza, Fiorella Orellana-Peralta, Alvaro Marcelo-Rodríguez, Eduardo Verne, Mónica Esquivel-Vizcarra, Wilmer Silva-Caso, Miguel Angel Aguilar-Luis, Pablo Weilg, Verónica Casabona-Oré, Claudia Ugarte, Luis J Del Valle   +10 more
doaj   +1 more source

Ceftriaxone‐associated immune haemolytic anaemia: A patient‐level systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Ceftriaxone can cause acute haemolysis. Its clinical presentation, risk factors, and outcomes remain incompletely characterized. We conducted a systematic review of published cases with patient‐level data, following international guidelines and with registration in PROSPERO (CRD420261338709). Reports were identified through three bibliographic
Sonja Miotti, Giada Wyttenbach, Mario G. Bianchetti, Camilla Lavagno, Pietro Camozzi, Gregorio P. Milani, Renato Gualtieri, Sebastiano A. G. Lava, Pietro B. Faré, Simone Janett   +9 more
wiley   +1 more source

Mycoplasma pneumonia : an unusual cause of acute myocarditis in childhood [PDF]

, 2006
Mycoplasma pneumoniae is primarily a respiratory pathogen but may affect exhibit a diverse range of presentations from asymptomatic infection to life threatening conditions. Myocarditis of varying severity is an unusual complication.
Bailey, Mark, Muscat, C., Barbara, Christopher, Grech, Victor E., Formosa Gouder, Mireille   +4 more
core  

Bridging the translational gap in clinical nanomedicine: From rational design to clinical reality

BMEMat, EarlyView.
Nanotechnology offers a multi‐faceted approach to modern healthcare, encompassing high‐sensitivity diagnostic imaging, innovative vaccine delivery, and targeted therapeutics. This review explores how these nanomedicine applications address critical challenges in cancer recurrence and the treatment of neurologic and respiratory diseases to combat rising
Ahmed H. Ghonaim, Marwa Ahmed El‐Naka, Wedad M. Nageeb, Atta Ullah Khan, Noura M. Seleem, Aliaa Abdelghafar, Doaa Zamel, Yang Liu, Qigai He, Wentao Li   +9 more
wiley   +1 more source

Mycoplasma Pneumoniae infections in the Maltese Islands [PDF]

, 2000
Mycoplasma pneumoniae is a free living micro-organism which is classified in the family Mycoplasmataceae. It is primarily a human respiratory pathogen and the infection may vary from a mild pharyngitis to a pneumonia. M. pneumoniae infections are usually
Portelli, Alfred V., Barbara, Christopher   +1 more
core  

The association between Mycoplasma pneumoniae infection and speech and language impairment: A nationwide population-based study in Taiwan.

PLoS ONE, 2017
Manifestations of Mycoplasma pneumoniae infection can range from self-limiting upper respiratory symptoms to various neurological complications, including speech and language impairment.
Ching-Shu Tsai, Vincent Chin-Hung Chen, Yao-Hsu Yang, Tai-Hsin Hung, Mong-Liang Lu, Kuo-You Huang, Michael Gossop   +6 more
doaj   +1 more source